MONIS-XR 60 mg Tablets Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of MONIS-XR 60 mg Tablets.

Available Products of MONIS-XR 60 mg Tablets

MONIS-XR 60 mg Tablets 30's

Reg#: 022991

Description of MONIS-XR 60 mg Tablets

Each tablet contains:Isosorbide mono nitrate…….60mg

Medicine Info

Pack Size: 30's

Company: Maple Pharmaceuticals (Pvt) Ltd

Price of MONIS-XR 60 mg Tablets

Price: Rs. 682.77

Related Keywords

  • MONIS-XR 60 mg Tablets price in Pakistan
  • MONIS-XR 60 mg Tablets tablet price
  • MONIS-XR 60 mg Tablets Capsule price
  • Maple Pharmaceuticals (Pvt) Ltd MONIS-XR 60 mg Tablets price
  • Buy MONIS-XR 60 mg Tablets online
  • MONIS-XR 60 mg Tablets nitrate60mg uses
  • MONIS-XR 60 mg Tablets syrup price
  • MONIS-XR 60 mg Tablets pack 30's cost

MONIS-XR 60 mg Tablets 10x10's

Reg#: 022991

Description of MONIS-XR 60 mg Tablets

Each tablet contains:Isosorbide mono nitrate…….60mg

Medicine Info

Pack Size: 10x10's

Company: Maple Pharmaceuticals (Pvt) Ltd

Price of MONIS-XR 60 mg Tablets

Price: Rs. 1665.55

Related Keywords

  • MONIS-XR 60 mg Tablets price in Pakistan
  • MONIS-XR 60 mg Tablets tablet price
  • MONIS-XR 60 mg Tablets Capsule price
  • Maple Pharmaceuticals (Pvt) Ltd MONIS-XR 60 mg Tablets price
  • Buy MONIS-XR 60 mg Tablets online
  • MONIS-XR 60 mg Tablets nitrate60mg uses
  • MONIS-XR 60 mg Tablets syrup price
  • MONIS-XR 60 mg Tablets pack 10x10's cost

Alternatives brands of MONIS-XR 60 mg Tablets

Explore alternative brands for MONIS-XR 60 mg Tablets below.

View Alternatives

Explore More Medicines

DINEMIC 20mg Tablet

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 1109.6483

MEFCID Suspension

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 70.6665

Mapvip Tablet

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 38016.0000

Megab Capsules

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 266.6400

Mapdilol Tablets

Maple Pharmaceuticals (Pvt) Ltd

MRP: Rs. 264.0000

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!